Company Intelligence
ConcertAI
ConcertAI provides enterprise-grade artificial intelligence solutions, delivering specialized ConcertAI Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- Cambridge, United States
- Website
- www.concertai.com
- Founded
- 2017
- Status
- Active
- Products
- 1
- Reports
- 8
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
ConcertAI is a Healthcare AI company based in Cambridge, United States, founded in 2017.
Cambridge oncology analytics company applying agentic AI and real-world data to clinical development and care delivery.
Verified founder profiles on Brel: Jeff Elton PhD, Jeff Elton, Romesh Wadhwani.
What it builds
ConcertAI Platform
Why It Matters
ConcertAI provides enterprise-grade artificial intelligence solutions, delivering specialized ConcertAI Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
ConcertAI — Healthcare Analytics
Explore ConcertAI — Healthcare Analytics by ConcertAI. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical…
View product intelligence
Founders
People linked to this company in the Brel founder graph.
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
ConcertAI
Industry
Industries served
- Healthcare Analytics
Products
Technologies
Capabilities
ConcertAI's AI stack emphasizes agentic workflows — purpose-built assistants and agents trained for life-sciences use cases rather than general-purpose models adapted post…
Features
Oncology-focused AI SaaS platform (CARAai) and real-world data solutions spanning clinical development, CancerLinQ provider tools, TeraRecon imaging augmentation, and commercial patient-journey analytics.
Deployment
- Oncology-focused AI SaaS platform (CARAai) and real-world data solutions spanning clinical development, CancerLinQ provider tools, TeraRecon imaging augmentation, and commercial patient-journey analytics.
- Pharmaceutical teams want repeatable SaaS modules with audit trails, not bespoke consulting projects rebuilt for every brand launch.
Integrations
Hospital oncology leaders evaluating trial-matching tools should ask whether vendor AI runs inside their existing CancerLinQ or EHR context — integration depth…
Country
Use cases
Related companies
Official Resources
Official and developer links on file for this company.
Latest Developments
Verified developments and timeline notes on file.
Frequently Asked Questions
What does ConcertAI do?
ConcertAI specializes in artificial intelligence, developing ConcertAI Platform to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is ConcertAI based and when was it founded?
ConcertAI is based in United States and was founded in 2017.
What are the main products offered by ConcertAI?
The flagship platform from ConcertAI is ConcertAI Platform, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of ConcertAI?
ConcertAI primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.